Literature DB >> 21854877

Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment.

Jennifer M Rothberg1, Mansoureh Sameni, Kamiar Moin, Bonnie F Sloane.   

Abstract

Our laboratory has had a longstanding interest in how the interactions between tumors and their microenvironment affect malignant progression. Recently, we have focused on defining the proteolytic pathways that function in the transition of breast cancer from the pre-invasive lesions of ductal carcinoma in situ (DCIS) to invasive ductal carcinomas (IDCs). We use live-cell imaging to visualize, localize and quantify proteolysis as it occurs in real-time and thereby have established roles for lysosomal cysteine proteases both pericellularly and intracellularly in tumor proteolysis. To facilitate these studies, we have developed and optimized 3D organotypic co-culture models that recapitulate the in vivo interactions of mammary epithelial cells or tumor cells with stromal and inflammatory cells. Here we will discuss the background that led to our present studies as well as the techniques and models that we employ. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21854877      PMCID: PMC3232330          DOI: 10.1016/j.bbapap.2011.07.025

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  173 in total

Review 1.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

2.  Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions.

Authors:  R J Gillies; R Martinez-Zaguilan; G M Martinez; R Serrano; R Perona
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.

Authors:  Kamiar Moin; Mansoureh Sameni; Bernadette C Victor; Jennifer M Rothberg; Raymond R Mattingly; Bonnie F Sloane
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

4.  Immunofluorescent studies on the occurrence of cathepsin B1 at tumor cell surfaces.

Authors:  B Sylvén; O Snellman; P Sträuli
Journal:  Virchows Arch B Cell Pathol       Date:  1974

5.  The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.

Authors:  Birgitte Vrou Offersen; Boye Schnack Nielsen; Gunilla Høyer-Hansen; Fritz Rank; Stephen Hamilton-Dutoit; Jens Overgaard; Peter A Andreasen
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 6.  The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.

Authors:  Anna C Erickson; Mary Helen Barcellos-Hoff
Journal:  Expert Opin Ther Targets       Date:  2003-02       Impact factor: 6.902

7.  Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors.

Authors:  Paul A Schornack; Robert J Gillies
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

Review 8.  Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis.

Authors:  Hideki Yamaguchi; Tsukasa Oikawa
Journal:  Oncotarget       Date:  2010-09

Review 9.  Extracellular proteolysis in transgenic mouse models of breast cancer.

Authors:  Kasper Almholt; Kirsty Anne Green; Anna Juncker-Jensen; Boye Schnack Nielsen; Leif Røge Lund; John Rømer
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

Review 10.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

View more
  11 in total

1.  Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger-1 (NHE1).

Authors:  Samantha S Dykes; ChongFeng Gao; William K Songock; Rebecca L Bigelow; George Vande Woude; Jason M Bodily; James A Cardelli
Journal:  Mol Carcinog       Date:  2016-08-22       Impact factor: 4.784

2.  Acid-mediated tumor proteolysis: contribution of cysteine cathepsins.

Authors:  Jennifer M Rothberg; Kate M Bailey; Jonathan W Wojtkowiak; Yael Ben-Nun; Matthew Bogyo; Ekkehard Weber; Kamiar Moin; Galia Blum; Raymond R Mattingly; Robert J Gillies; Bonnie F Sloane
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

Review 3.  Developments in preclinical cancer imaging: innovating the discovery of therapeutics.

Authors:  James R W Conway; Neil O Carragher; Paul Timpson
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

Review 4.  Cathepsin B: multiple roles in cancer.

Authors:  Neha Aggarwal; Bonnie F Sloane
Journal:  Proteomics Clin Appl       Date:  2014-03-26       Impact factor: 3.494

5.  On-demand dissolution of modular, synthetic extracellular matrix reveals local epithelial-stromal communication networks.

Authors:  Jorge Valdez; Christi D Cook; Caroline Chopko Ahrens; Alex J Wang; Alexander Brown; Manu Kumar; Linda Stockdale; Daniel Rothenberg; Kasper Renggli; Elizabeth Gordon; Douglas Lauffenburger; Forest White; Linda Griffith
Journal:  Biomaterials       Date:  2017-03-23       Impact factor: 12.479

Review 6.  Metastasis review: from bench to bedside.

Authors:  Ali Mohammad Alizadeh; Sadaf Shiri; Sadaf Farsinejad
Journal:  Tumour Biol       Date:  2014-08-08

7.  Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion.

Authors:  Bernadette C Victor; Arulselvi Anbalagan; Mona M Mohamed; Bonnie F Sloane; Dora Cavallo-Medved
Journal:  Breast Cancer Res       Date:  2011-11-17       Impact factor: 6.466

8.  Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate.

Authors:  Ruth Duncan; Yee-Nee Sat-Klopsch; Angelika M Burger; Michael C Bibby; Heinz H Fiebig; Edward A Sausville
Journal:  Cancer Chemother Pharmacol       Date:  2013-08       Impact factor: 3.333

Review 9.  Inflammatory breast cancer: New factors contribute to disease etiology: A review.

Authors:  Mona M Mohamed; Diaa Al-Raawi; Salwa F Sabet; Mohamed El-Shinawi
Journal:  J Adv Res       Date:  2013-06-14       Impact factor: 10.479

10.  Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target.

Authors:  Thomas Reinheckel; Christoph Peters; Achim Krüger; Boris Turk; Olga Vasiljeva
Journal:  Front Pharmacol       Date:  2012-07-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.